Market Overview:
The global elcatonin market is expected to grow at a CAGR of xx% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising demand for elcatonin in pharmaceutical intermediates, chemical intermediate, and other applications. Elcatonin is a polypeptide hormone that is used for the treatment of various medical conditions such as Duchenne muscular dystrophy (DMD), Becker muscular dystrophy (BMD), and sarcopenia. It also helps in increasing muscle mass and strength.
Product Definition:
Elcatonin is a peptide that inhibits calcitonin gene-related peptide (CGRP) and has been shown to be effective in the treatment of chronic pain.
Purity>97%:
Purity 97% is a highly concentrated protein solution, which contains approximately 2.5 to 3.75 grams of protein per liter. It's produced by the ultrafiltration process and has no additives or added sugar like other whey products do have (otherwise it would be too sweet for consumption).
It’s used in various applications such as nutritional supplements, infant formula, clinical nutrition and others where high purity proteins are required.
Purity
Purity 97% is a highly concentrated solution of catalase and is used in the treatment of certain eye diseases. It helps in increasing the oxygen level in the blood by eliminating harmful anions and cations, thus promoting tissue healing.
It also helps to reduce intraocular pressure (IOP), which may result from glaucoma, hypertension, or diabetes mellitus; it can also occur as a side effect of cancer chemotherapy.
Application Insights:
Elcatonin is widely used in the pharmaceutical industry as intermediates for the manufacture of various drugs. The drug discovery segment held the largest market share, accounting for over 50% of global revenue in 2017. This can be attributed to growing R&D activities pertaining to elcatonin and its derivatives that have a high potential as therapeutic drugs.
The chemical intermediate application segment is expected to witness significant growth over the forecast period owing to increasing demand from various industries including textile, paper and pulp, cosmetics, paints and coatings etc. Elcatonin has been reported to have excellent properties such as antifungal, antibacterial & antiseptic which makes it highly suitable for use in manufacturing chemicals like pesticides and herbicides which are extensively used across several industries worldwide.
Regional Analysis:
North America accounted for the largest share of global revenue in 2017. The region is expected to maintain its dominance over the forecast period owing to presence of a large number of key companies and well-established manufacturing sector. In addition, high R&D investment by domestic as well as foreign players coupled with technological advancements are also contributing towards regional growth.
Asia Pacific is anticipated to witness significant growth during the forecast period due to increasing focus on developing pharmaceuticals and chemicals industries in emerging economies such as China, India, South Korea & Taiwan etc. Furthermore, favorable government policies promoting investments along with growing awareness regarding elcatonin usage will drive regional market further.
In terms of revenue Europe was second major contributor after North America in 2017 owing to high purity level product availability across majority of countries especially Germany and France etc.
Growth Factors:
- Increasing prevalence of chronic diseases such as heart failure, hypertension, and diabetes which will lead to an increase in demand for elcatonin.
- Growing geriatric population who are at a higher risk of developing chronic diseases and are more likely to require elcatonin for treatment.
- Increasing use of elcatonin in combination with other drugs for the treatment of various chronic diseases.
- Technological advancements that will allow manufacturers to develop new formulations and delivery methods for elcatonin which will improve patient compliance and increase market uptake.
Scope Of The Report
Report Attributes
Report Details
Report Title
Elcatonin Market Research Report
By Type
Purity>97%, Purity<97%
By Application
Pharmaceutical intermediates, Chemical Intermediate, Others
By Companies
Creative Peptides, Alfa Chemistry, THREEB-MED, Aksci, CHEMOS, Carbone Scientific, Prospecbio, AsahiKASEI, BioVision
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
223
Number of Tables & Figures
157
Customization Available
Yes, the report can be customized as per your need.
Global Elcatonin Market Report Segments:
The global Elcatonin market is segmented on the basis of:
Types
Purity>97%, Purity<97%
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Pharmaceutical intermediates, Chemical Intermediate, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Creative Peptides
- Alfa Chemistry
- THREEB-MED
- Aksci
- CHEMOS
- Carbone Scientific
- Prospecbio
- AsahiKASEI
- BioVision
Highlights of The Elcatonin Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Purity>97%
- Purity<97%
- By Application:
- Pharmaceutical intermediates
- Chemical Intermediate
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Elcatonin Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Elcatonin is a natural product isolated from the fungus Aspergillus niger. It has been shown to have anti-inflammatory and immunomodulatory properties.
Some of the major companies in the elcatonin market are Creative Peptides, Alfa Chemistry, THREEB-MED, Aksci, CHEMOS, Carbone Scientific, Prospecbio, AsahiKASEI, BioVision.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Elcatonin Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Elcatonin Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Elcatonin Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Elcatonin Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Elcatonin Market Size & Forecast, 2020-2028
4.5.1 Elcatonin Market Size and Y-o-Y Growth
4.5.2 Elcatonin Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Purity>97%
5.2.2 Purity<97%
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Pharmaceutical intermediates
6.2.2 Chemical Intermediate
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Elcatonin Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Elcatonin Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Purity>97%
9.6.2 Purity<97%
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Pharmaceutical intermediates
9.10.2 Chemical Intermediate
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Purity>97%
10.6.2 Purity<97%
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Pharmaceutical intermediates
10.10.2 Chemical Intermediate
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Purity>97%
11.6.2 Purity<97%
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Pharmaceutical intermediates
11.10.2 Chemical Intermediate
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Purity>97%
12.6.2 Purity<97%
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Pharmaceutical intermediates
12.10.2 Chemical Intermediate
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Purity>97%
13.6.2 Purity<97%
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Pharmaceutical intermediates
13.10.2 Chemical Intermediate
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Elcatonin Market: Competitive Dashboard
14.2 Global Elcatonin Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Creative Peptides
14.3.2 Alfa Chemistry
14.3.3 THREEB-MED
14.3.4 Aksci
14.3.5 CHEMOS
14.3.6 Carbone Scientific
14.3.7 Prospecbio
14.3.8 AsahiKASEI
14.3.9 BioVision
